Literature DB >> 19116370

Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine.

Ken-ichi Hosoya1, Akihide Makihara, Yuki Tsujikawa, Daisuke Yoneyama, Shinobu Mori, Tetsuya Terasaki, Shin-ichi Akanuma, Masatoshi Tomi, Masanori Tachikawa.   

Abstract

The purpose of the present study was to characterize rat organic anion transporter (Oat) 3 (Oat3, Slc22a8) in the efflux transport at the inner blood-retinal barrier (BRB). Reverse transcription-polymerase chain reaction analysis showed that rat (r) Oat3 mRNA is expressed in retinal vascular endothelial cells (RVECs), but not rOat1 and rOat2 mRNA. The expression of Oat3 in the retina and human cultured retinal endothelial cells was further confirmed by Western blot analysis. Immunohistochemical staining in RVECs showed that rOat3 is colocalized with glucose transporter 1, but not P-glycoprotein, suggesting that rOat3 is possibly located at the abluminal membrane of the RVEC. The contribution of rOat3 to the efflux of [(3)H]p-aminohippuric acid ([(3)H]PAH), [(3)H]benzylpenicillin ([(3)H]PCG), and [(14)C]6-mercaptopurine ([(14)C]6-MP), substrates of rOat3, from the vitreous humor/retina to the circulating blood across the inner BRB was evaluated using the microdialysis method. [(3)H]PAH, [(3)H]PCG, [(14)C]6-MP, and [(14)C] or [(3)H]d-mannitol, a bulk flow marker, were biexponentially eliminated from the vitreous humor after vitreous bolus injection. The elimination rate constant of [(3)H]PAH, [(3)H]PCG, and [(14)C]6-MP during the terminal phase was approximately 2-fold greater than that of d-mannitol. This efflux transport was reduced in the retinal presence of probenecid, PAH, and PCG, whereas it was not inhibited by digoxin. In conclusion, rOat3 is expressed at the inner BRB and involved in the vitreous humor/retina-to-blood transport of PAH, PCG, and 6-MP. This transport system is one mechanism to limit the retinal distribution of PAH, PCG, and 6-MP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116370     DOI: 10.1124/jpet.108.146381

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

Review 1.  Inner blood-retinal barrier transporters: role of retinal drug delivery.

Authors:  Ken-ichi Hosoya; Masanori Tachikawa
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

Review 2.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 3.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 4.  Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization.

Authors:  Amelia N Deitchman; M Tobias Heinrichs; Vipada Khaowroongrueng; Satyawan B Jadhav; Hartmut Derendorf
Journal:  AAPS J       Date:  2016-12-09       Impact factor: 4.009

5.  Blood-to-Retina Transport of Fluorescence-Labeled Verapamil at the Blood-Retinal Barrier.

Authors:  Yoshiyuki Kubo; Ayumi Nakazawa; Shin-Ichi Akanuma; Ken-Ichi Hosoya
Journal:  Pharm Res       Date:  2018-03-12       Impact factor: 4.200

6.  Safety Assessment of Formulation Vehicles Following Intravitreal Administration in Rabbits.

Authors:  Shirley A Aguirre; Hovhannes J Gukasyan; Husam S Younis; Wenhu Huang
Journal:  Pharm Res       Date:  2018-07-09       Impact factor: 4.200

7.  Simvastatin protects photoreceptors from oxidative stress induced by all-trans-retinal, through the up-regulation of interphotoreceptor retinoid binding protein.

Authors:  Ting Zhang; Mark Gillies; Ying Wang; Weiyong Shen; Bobak Bahrami; Shaoxue Zeng; Meidong Zhu; Wenjuan Yao; Fanfan Zhou; Michael Murray; Ke Wang; Ling Zhu
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

8.  Lipophilicity and transporter influence on blood-retinal barrier permeability: a comparison with blood-brain barrier permeability.

Authors:  Ken-ichi Hosoya; Atsushi Yamamoto; Shin-ichi Akanuma; Masanori Tachikawa
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

9.  Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.

Authors:  Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Uday B Kompella
Journal:  Brain Res Bull       Date:  2009-09-15       Impact factor: 4.077

10.  Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.

Authors:  Rajendra S Kadam; Uday B Kompella
Journal:  J Pharmacol Exp Ther       Date:  2009-11-19       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.